氯氮平治疗难治性精神分裂症的开放性临床试验。
An open clinical trial with clozapine in treatment-resistant schizophrenics.
机构信息
A.K. AGARWAL, MD., DPM., Professor & Head, K.G.'s Medical College, Lucknow.
出版信息
Indian J Psychiatry. 1997 Jan;39(1):70-5.
Abstract
In an open trial, drug-resistant schizophrenics were treated with clozapine for sixteen weeks. The patients were rated on BPRS, PANSS, Side effects scale and Global Impression Scale at weeks 0. 9 and 16. A battery of base-line investigations were done, and hemogram was repeated at weekly intervals. Of the total 29 patient included. 25 completed the trial. The patients showed significant improvement on both BPRS and PANSS, although the improvement was more in initial weeks than between 9 and 16 weeks. The most common side effects observed were sedation, hypersalivation and tachycardia. Issues of response of clozapine on negative symptoms and a longer duration of the drug therapy are discussed.
摘要
在一项开放性试验中，用氯氮平治疗耐药性精神分裂症患者 16 周。在第 0、9 和 16 周时，根据 BPRS、PANSS、副作用量表和总体印象量表对患者进行评分。进行了一系列基线调查，并在每周间隔时重复血常规检查。在总共 29 名患者中，有 25 名完成了试验。尽管在第 9 周至第 16 周之间的改善不如最初几周明显，但患者在 BPRS 和 PANSS 上均有显著改善。最常见的副作用是镇静、唾液分泌过多和心动过速。讨论了氯氮平对阴性症状的反应和更长的药物治疗持续时间的问题。
相似文献
1
An open clinical trial with clozapine in treatment-resistant schizophrenics.氯氮平治疗难治性精神分裂症的开放性临床试验。
Indian J Psychiatry. 1997 Jan;39(1):70-5.
2
Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study.氯氮平治疗难治性精神分裂症时加用美金刚：一项开放标签的1年延长期研究。
Psychol Med. 2017 Jan;47(2):363-375. doi: 10.1017/S0033291716002476. Epub 2016 Oct 25.
3
Initial experience with clozapine in Woodbridge Hospital.氯氮平在伍德布里奇医院的初步应用经验。
Singapore Med J. 1997 Aug;38(8):336-8.
4
Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia.抗精神病药物治疗难治性精神分裂症的改善时间过程。
Br J Psychiatry. 2011 Oct;199(4):275-80. doi: 10.1192/bjp.bp.110.083907.
5
[Clozapine and refractory schizophrenia. Long-term prospective study of 20 patients].[氯氮平与难治性精神分裂症。20例患者的长期前瞻性研究]
Encephale. 1994 Nov-Dec;20(6):767-75.
6
[Clinical effects of clozapine: effect on negative symptoms].氯氮平的临床效果：对阴性症状的影响
Encephale. 1996 Jul-Aug;22(4):287-92.
7
An open comparison of clozapine and risperidone in treatment-resistant schizophrenia.氯氮平与利培酮治疗难治性精神分裂症的开放性对照研究。
Pharmacopsychiatry. 1998 Jan;31(1):25-9. doi: 10.1055/s-2007-979291.
8
Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial.苯甲酸钠，一种 D-氨基酸氧化酶抑制剂，添加到氯氮平中治疗精神分裂症：一项随机、双盲、安慰剂对照试验。
Biol Psychiatry. 2018 Sep 15;84(6):422-432. doi: 10.1016/j.biopsych.2017.12.006. Epub 2017 Dec 26.
9
Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine.高频重复经颅磁刺激对氯氮平治疗的抗阴性症状治疗抵抗性精神分裂症患者的疗效。
Schizophr Res. 2019 Jun;208:370-376. doi: 10.1016/j.schres.2019.01.021. Epub 2019 Jan 29.
10
[A new therapeutic approach tp drug-resistant schizophrenia: clozapine. Long-term prospective study in 16 patients].[一种治疗耐药性精神分裂症的新方法：氯氮平。对16例患者的长期前瞻性研究]
Acta Psychiatr Belg. 1992;92(6):323-38.
引用本文的文献
1
Research on antipsychotics in India.印度的抗精神病药物研究。
Indian J Psychiatry. 2010 Jan;52(Suppl 1):S317-40. doi: 10.4103/0019-5545.69261.
2
An overview of Indian research in schizophrenia.印度精神分裂症研究概述。
Indian J Psychiatry. 2010 Jan;52(Suppl 1):S159-72. doi: 10.4103/0019-5545.69229.
3
Schizophrenia research: Indian scene in last decade.精神分裂症研究：过去十年的印度情况。
Indian J Psychiatry. 2004 Apr;46(2):115-24.
4
Clozapine: Current perspective.氯氮平：现状。
Indian J Psychiatry. 2007 Oct;49(4):271-6. doi: 10.4103/0019-5545.37668.
本文引用的文献
1
Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns.
Hosp Community Psychiatry. 1993 Dec;44(12):1145-9. doi: 10.1176/ps.44.12.1145.
2
Patient response and resource management: another view of clozapine treatment of schizophrenia.
Am J Psychiatry. 1995 Jun;152(6):827-32. doi: 10.1176/ajp.152.6.827.
3
Clozapine: is another view valid?氯氮平：另一种观点是否正确？
Am J Psychiatry. 1995 Jun;152(6):821-5. doi: 10.1176/ajp.152.6.821.
4
The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years.氯氮平长期治疗精神分裂症的效果：一项对96例接受氯氮平治疗长达13年患者的回顾性研究。
Acta Psychiatr Scand. 1988 May;77(5):524-9. doi: 10.1111/j.1600-0447.1988.tb05164.x.
5
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.氯氮平用于难治性精神分裂症。与氯丙嗪的双盲对照研究。
Arch Gen Psychiatry. 1988 Sep;45(9):789-96. doi: 10.1001/archpsyc.1988.01800330013001.
6
Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain.典型和非典型抗精神病药物对D2和S2受体的占有率：大鼠脑的放射自显影分析
Brain Res Bull. 1986 Apr;16(4):517-25. doi: 10.1016/0361-9230(86)90181-4.
7
Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients.六个月氯氮平治疗对慢性精神分裂症患者生活质量的影响。
Hosp Community Psychiatry. 1990 Aug;41(8):892-7. doi: 10.1176/ps.41.8.892.
8
Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.氯氮平：其药理特性及在精神分裂症治疗中的应用综述
Drugs. 1990 Nov;40(5):722-47. doi: 10.2165/00003495-199040050-00007.
9
Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites.典型和非典型抗精神病药物与5-HT1C和5-HT2位点的结合：氯氮平与5-HT1C位点有强烈相互作用。
Eur J Pharmacol. 1990 Nov 20;191(1):93-6. doi: 10.1016/0014-2999(90)94100-c.
10
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine.对治疗精神分裂症的氯氮平有高亲和力的人类多巴胺D4受体基因的克隆。
Nature. 1991 Apr 18;350(6319):610-4. doi: 10.1038/350610a0.
Zotero 插件